PhN(P(OC6H4OMe-o)2)2 | 791070-36-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: PhN(P(OC6H4OMe-o)2)2
• 英文别名: PNP；N,N-bis[bis(2-methoxyphenoxy)phosphanyl]aniline
• CAS: 791070-36-5
• 化学式: C₃₄H₃₃NO₈P₂
• 分子量: 645.585
• InChiKey: WLLGFPQJLPZXAY-UHFFFAOYSA-N

物化性质

• 熔点：
  100-102 °C(Solv: dichloromethane (75-09-2); hexane (110-54-3))
• 沸点：
  703.2±70.0 °C(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  9.2
• 重原子数：
  45
• 可旋转键数：
  15
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  77.1
• 氢给体数：
  0
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  PhN(P(OC6H4OMe-o)2)2 以 二氯甲烷 为溶剂， 生成 [Au2(2,2'-bipyridine)2[μ-PhN(P(OC6H4OMe-o)2)2]
  参考文献：
  名称：

  双，四和六核AuI和双核AgI络合物以及包含苯基氨基双（亚膦酸酯），PhN {P（OC6H4OMe-o）2} 2和吡啶基配体的AgI配位聚合物。

  摘要：

  苯氨基双（亚膦酸酯），PhN {P（OC6H4OMe-o）2} 2（1）（PNP）与[AuCl（SMe2）]以适当比例反应，得到双核和单核络合物[（AuCl）2 （micro-PNP）]（2）和[（AuCl）（PNP）] 2（3）收率很高。用2当量的AgX（X = OTf或ClO4）处理2，然后添加1或2,2'-联吡啶得到[Au2（micro-PNP）2]（OTf）2（4）和[Au2（C10H8N2） ）2（micro-PNP）]（ClO4）2（5）。同样，大环[Au4（C4H4N2）2（micro-PNP）2]（ClO4）4（6），[Au4（C10H8N2）2（micro-PNP）2]（ClO4）4（7）和[Au6（ C3H3N3）2（micro-PNP）3]（ClO4）6（8）是在AgClO 4存在下，用吡嗪，4,4'-联吡啶或1,3,5-三嗪处理2而获得的。 1与摩尔比为1：2的Ag

  DOI：

  10.1021/ic702133f
• 作为产物：
  描述：

  N,N'-bis(dichlorophosphino)aniline 、 木榴油 在 三乙胺 作用下， 以 乙醚 为溶剂， 反应 24.0h， 以84%的产率得到PhN(P(OC6H4OMe-o)2)2
  参考文献：
  名称：

  Synthesis and derivatization, structures and transition metal (Mo(0), Fe(II), Pd(II) and Pt(II)) complexes of phenylaminobis(diphosphonite), PhN{P(OC6H4OMe-o)2}2

  摘要：

  The synthesis, derivatization and coordination behavior of a new aminobis(diphosphonite), PhN{P(OC6H4OMe-o)(2)}(2) (1) is described. The ligand 1 reacts with H2O2, elemental sulfur or selenium to give the corresponding dichalcogenides PhN{P(E)(OC6H4OMe-o)(2)}(2) (E = O, 2; S, 3; Se, 4) in good yield. Reactions of 1 with Mo(CO)(6), Pd(NCCH3)(2)Cl-2 and Pt(COD)Cl-2 resulted in the formation of the chelate complexes, Mo(CO)(4)[PhN{P(OC6H4OMe-o)(2)}(2)] (5) and MCl2[PhN{P(OC6H4OMe-o)(2)}(2)] (M = Pd,7; M = Pt, 8) whereas in the reaction of 1 with [CpFe(CO)(2)](2), one of the P-N bonds cleaves due to the metal assisted hydrolysis to give a mononuclear complex, [CpFe(CO){P(O)(OC6H4OMe-o)(2)}{PhN(H)(P(OC6H4OMe-o)(2))}] (6). The molecular structures of 1, 4, 5 and 6 are determined by X-ray studies. (C) 2004 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.jorganchem.2004.08.003

文献信息

• Group 11 Metal Chemistry of a Tetradentate Ligand, Phenylene-1,4-diaminotetra(phosphonite), <i>p</i>-C₆H₄[N{P(OC₆H₄OMe-<i>o</i>)₂}₂]₂
  作者：Chelladurai Ganesamoorthy、Maravanji S. Balakrishna、Joel T. Mague

  DOI：10.1021/ic900085e

  日期：2009.4.20

  , p-C6H4[NP(OC6H4OMe-o)2}2]2 (P2NΦNP2) (1)) is described. The flexional conformations in 1 leads to interesting structural variations in transition-metal complexes. The reaction of 1 with 4 equiv of CuX (where X = Br and I) produce the tetranuclear complexes, [Cu2(μ-X)2(NCCH3)2}2(μ-P2NΦNP2)] (where X = Br (2) or X = I (3)) in quantitative yield. Treatment of 3 with an excess of pyridine, 2-(pipe

  四齿配体（亚苯基-1,4-二氨基四（亚膦酸酯），p -C 6 H 4 [N P（OC 6 H 4 OMe- o）2 } 2 ]的Cu I，Ag I和Au I化学2（P 2 NΦNP 2）（1））进行说明。该节弯曲构象在1只带来了一些有趣的结构变化在过渡金属配合物。的反应1与4当量的CuX（其中X = Br和I）产生的四核配合物，[的Cu 2（μ-X）2（NCCH 3）2 } 2（μ-P 2 NΦNP 2）]（其中X = Br的（2）或X = I（3））以定量产率。的治疗3与过量的吡啶，2-（哌嗪-1-基）嘧啶和吡唑，得到四取代的衍生物，[的Cu 2（μ-I）2（L）2 } 2（μ-P 2 NΦNP 2）]（其中L =吡啶（4），2-（哌嗪-1-基）嘧啶（5），或吡唑（6））。3的相似反应用1,10-菲咯啉（phen）的和2,2'-联吡啶以1：2的摩尔比，得到二取代的衍生物，[（铜2（
• Di- and Tetranuclear Copper(I) Complexes Containing Phenylaminobis(phosphonite), PhN{P(OC₆H₄OMe-<i>o</i>)₂}₂, and Their Reactivity toward Bipyridyl Ligands
  作者：Chelladurai Ganesamoorthy、Maravanji S. Balakrishna、Paulose P. George、Joel T. Mague

  DOI：10.1021/ic061883j

  日期：2007.2.1

  2 equiv of CuI to give a binuclear complex, Cu2(mu2-I)2(NCCH3)2(mu-PNP) (2), whereas similar reactions with CuCl and CuBr furnish tetranuclear "ladder"-type complexes, Cu4(mu2-X)2(mu3-X)2(mu-PNP)2 (3, X = Cl; 4, X = Br), in excellent yield. The complex 2 when heated under vacuum turns into the tetranuclear complex 5 in a reversible fashion. Similarly, the complexes 3 and 4 on dissolution in CH3CN dissociate

  氨基双（亚膦酸酯）PhN（P（OC6H4OMe-o）2）2（PNP; 1）与2当量的CuI反应生成双核络合物Cu2（mu2-I）2（NCCH3）2（mu-PNP）（ 2），而与CuCl和CuBr的类似反应则提供了四核“阶梯”型配合物，而Cu4（mu2-X）2（mu3-X）2（mu-PNP）2（3，X = Cl; 4，X = Br ），且产量极高。当在真空下加热时，络合物2以可逆的方式变成四核络合物5。类似地，在溶于CH 3 CN中的复合物3和4可逆地解离成相应的双核复合物，从中可以容易地再生四聚体复合物。用过量的吡啶处理2可得到杂取代的衍生物Cu2（mu2-I）2（C5H5N）2（mu-PNP）（6）。2与1：1和1：2比率的2,2'-联吡啶的相互作用产生了单取代和双取代的衍生物，Cu2（mu2-I）I（C10H8N2）（mu-PNP）（7）和[Cu2（mu2-I）（ ）2（mu-PNP）]
• Synthesis and structural studies of RhI, PdI, NiII complexes and one-pot synthesis of binuclear RuII complex [(η6-p-cymene)Ru(μ2-Cl)3Ru{PhN(P(OC6H4OMe-o)2)2}Cl]
  作者：Chelladurai Ganesamoorthy、Joel T. Mague、Maravanji S. Balakrishna

  DOI：10.1016/j.jorganchem.2007.04.019

  日期：2007.7

  The Rh-I, Ru-II, Pd-I and Ni-II complexes of the aminobis(phosphonite), PhN(P(OC6H4OMe-o)(2))(2) (1) are reported. The reactions of 1 with [Rh(COD)Cl](2) in 1:1 and 2:1 molar ratio afford the mono- and diolefin substituted chloro bridged chelate complexes, [(COD)Rh-2(mu(2)-Cl)(2)PhN(P(OC6H4OMe-o)(2))(2)}] (2) and [Rh(mu(2)-Cl)PhN(P(OC6H4OMe-o)(2))(2)}](2) (3), respectively. Similarly, the cationic mono- and bis-chelate complexes, [Rh(COD)(PhN(P(OC6H4OMe-o)(2))(2)}]OTf (4) and [RhPhN(P(OC6H4OMe-o)(2))(2)}(2)]OTf (5) are obtained by treating 1 with [Rh(COD)Cl](2) in the presence of AgOTf in appropriate ratios. The dinuclear Rh-I carbonyl complex, [RhCl(CO)mu-PhN(P(OC6H4OMe-o)(2))(2)}](2) (6) is prepared by treating 1 with 0.5 equiv. of [Rh(CO)(2)Cl](2). Reaction of 1 with cis-[NiBr2(DME)] (DME = 1,2-dimethoxyethane) affords [PhN(P(OC6H4OMe-o)(2))(2)} NiBr2] (7) whereas with [Ru-(eta(6)-p-cymene)Cl-2](2) in refluxing THF medium produces an interesting and rare bimetallic Ru-II complex, [(eta(6)-p-cymene)Ru(mu(2)-Cl)(3)RuPhN(P(OC6H4OMe-o)(2))(2))Cl] (8). Redox condensation of the Pd-0 and Pd-II derivatives with 1 affords the dinuclear Pd-I complex, [PdBrmu-PhN(P(OC6H4OMe-o)(2))(2)}](2) (9). The formation and structure of complexes 2-9 are assigned through various spectroscopic and micro analysis data. The molecular structures of 5 and 7-9 are confirmed by single crystal X-ray diffraction studies. (c) 2007 Elsevier B.V. All rights reserved.